MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$48,140K
Net Income
-$12,158K
Net Profit Margin
-25.26%
Unit: Thousand (K) dollars
Revenue Breakdown
US
EMEA
Asia Pacific
Other
Revenue Breakdown
Sales Channel Directly To Consum...
Sales Channel Through Intermedia...
Revenue Breakdown
Biotechnology Pharmaceutical Dis...
Academia And Government
Revenue Breakdown
Product
Service
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Total revenue, net
48,140
44,135
62,141
52,293
Total cost of sales
19,800
22,881
29,256
24,742
Gross profit
28,340
21,254
32,885
27,551
Research and development
9,741
9,604
8,961
8,956
Sales and marketing
13,174
11,646
13,131
11,666
General and administrative
16,825
18,467
16,386
16,121
Total operating expenses
39,740
39,717
38,478
36,743
Loss from operations
-11,400
-18,463
-5,593
-9,192
Interest expense
281
262
-725
494
Interest income
819
787
580
573
Other income (expense), net
-781
565
257
1,344
Total other income (expense), net
-243
1,090
1,562
1,423
Loss before income taxes
-11,643
-17,373
-4,031
-7,769
Provision for (benefit from) income taxes
515
1,493
40,045
-2,291
Net loss
-
-
-44,076*
-5,478
Less net loss allocated to noncontrolling interests
-
-
0*
-
Net loss
-12,158
-18,866
-
-
Net loss attributable to common stockholders, diluted
-
-
-44,076
-
Net loss, basic
-12,158
-18,866
-
-5,478
Basic Average Shares
129,460,518
128,704,934
128,162,122
127,547,859
Diluted Average Shares
129,460,518
128,704,934
128,162,122
127,547,859
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
1
2
3
4
Net loss, basic
-$12,158K
(-117.77%↓ Y/Y)
Net loss
-$12,158K
(-117.77%↓ Y/Y)
US
$28,220K
(18.10%↑ Y/Y)
EMEA
$11,304K
(-8.16%↓ Y/Y)
Asia Pacific
$7,915K
(0.61%↑ Y/Y)
Other
$701K
(-54.24%↓ Y/Y)
Loss before income
taxes
-$11,643K
Provision for (benefit
from) income taxes
$515K
(143.20%↑ Y/Y)
Total revenue, net
$48,140K
(5.57%↑ Y/Y)
Loss from operations
-$11,400K
(-7.30%↓ Y/Y)
Total other income
(expense), net
-$243K
(-106.31%↓ Y/Y)
Gross profit
$28,340K
(18.74%↑ Y/Y)
Interest income
$819K
(47.57%↑ Y/Y)
Total cost of sales
$19,800K
(-8.90%↓ Y/Y)
Total operating
expenses
$39,740K
(15.22%↑ Y/Y)
Other income
(expense), net
-$781K
(-121.06%↓ Y/Y)
Interest expense
$281K
(-32.13%↓ Y/Y)
General and
administrative
$16,825K
(24.34%↑ Y/Y)
Sales and marketing
$13,174K
(8.57%↑ Y/Y)
Research and development
$9,741K
(10.37%↑ Y/Y)
Buy us a coffee
Cytek Biosciences, Inc. (CTKB)
Cytek Biosciences, Inc. (CTKB)